Merck to acquire SmartCells
Merck & Co. has unveiled an agreement to buy SmartCells Inc., a private company developing a unique technology for the treatment of diabetes. Under the deal announced Thursday, Merck said it plans to acquire all outstanding stock of Beverly, Mass.-based SmartCells.